Allan, and then you have the Biomarker data that has only come to light recently showing extreme efficacy when using the Magic poor prognosis scores, where these cells make a massive difference.
The Magic control cohorts were between 10 and 30% probability of survival, versus those matching the Magic >0.29 score, that MSB treated having 64% survival in the GVHDD 001 trial.
They have also expanded the comparison to include the EAP children who also match the Magic algorithm, and I bet this will show the same extreme efficacy levels.
There is nothing that I know of for children SrGvHD and > 0.29 that is anywhere near as effective. Probably why it's approved in Japan an going gangbusters already
Why are PNV holders frequenting MSB?, page-14
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |